Aspen Pharmacare
Assessment date: Mar 2017
Aspen’s report makes the assumption that the reader already has confidence and trust in leadership and that anything it declares should be believed. Statements like: “sustaining life and health through high quality, affordable medicines”, are poorly (if at all) backed up by any substantive discussion of the issue, leaving the impression that the leadership has more important business to attend to.
Only in the area of talent attraction and management did the report impress in terms of appearing to be genuine and goal oriented. The poor effort to establish and embed a value system supporting company behaviour, and the overly defensive response to press criticism of its supply management are further examples of poor leadership maturity.
See the executive summary for a more complete overview of FarSight’s analysis for Aspen. Buy our full report for detailed analysis and supporting discussion.
